Renaissance Technologies’s Soleno Therapeutics SLNO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.79M Buy
+45,200
New +$3.79M 0.01% 1695
2023
Q4
Sell
-61,554
Closed -$1.82M 4095
2023
Q3
$1.82M Sell
61,554
-4,500
-7% -$133K ﹤0.01% 1926
2023
Q2
$283K Sell
66,054
-10,461
-14% -$44.8K ﹤0.01% 3154
2023
Q1
$164K Buy
76,515
+26,761
+54% +$57.4K ﹤0.01% 3347
2022
Q4
$99K Buy
49,754
+4,800
+11% +$9.55K ﹤0.01% 3621
2022
Q3
$75K Buy
44,954
+8,279
+23% +$13.8K ﹤0.01% 3667
2022
Q2
$102K Buy
36,675
+20,128
+122% +$56K ﹤0.01% 3849
2022
Q1
$55K Buy
16,547
+12,507
+310% +$41.6K ﹤0.01% 3897
2021
Q4
$25K Buy
4,040
+3,347
+483% +$20.7K ﹤0.01% 3834
2021
Q3
$10K Sell
693
-24,253
-97% -$350K ﹤0.01% 3414
2021
Q2
$427K Buy
+24,946
New +$427K ﹤0.01% 3023
2020
Q3
Sell
-9,617
Closed -$320K 3656
2020
Q2
$320K Buy
9,617
+1,853
+24% +$61.7K ﹤0.01% 3017
2020
Q1
$277K Sell
7,764
-953
-11% -$34K ﹤0.01% 3007
2019
Q4
$384K Sell
8,717
-1,708
-16% -$75.2K ﹤0.01% 2987
2019
Q3
$235K Buy
10,425
+898
+9% +$20.2K ﹤0.01% 3099
2019
Q2
$400K Buy
9,527
+5,285
+125% +$222K ﹤0.01% 3076
2019
Q1
$131K Buy
+4,242
New +$131K ﹤0.01% 3271
2017
Q4
Sell
-354
Closed -$14K 3488
2017
Q3
$14K Buy
+354
New +$14K ﹤0.01% 3163